Similar articles

• Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.

  Kang RH, Wong ML, Choi MJ, Paik JW, Lee MS. Kang RH, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1317-21. doi: 10.1016/j.pnpbp.2007.05.018. Epub 2007 Jun 7. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17618721 Clinical Trial.
• Interaction of 5-HTT and HTR1A gene polymorphisms in treatment responses to mirtazapine in patients with major depressive disorder.

  Chang HS, Lee HY, Cha JH, Won ES, Ham BJ, Kim B, Lee MS. Chang HS, et al. J Clin Psychopharmacol. 2014 Aug;34(4):446-54. doi: 10.1097/JCP.0000000000000143. J Clin Psychopharmacol. 2014. PMID: 24911443
• Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.

  Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF. Murphy GM Jr, et al. Arch Gen Psychiatry. 2004 Nov;61(11):1163-9. doi: 10.1001/archpsyc.61.11.1163. Arch Gen Psychiatry. 2004. PMID: 15520364 Clinical Trial.
• A risk-benefit assessment of mirtazapine in the treatment of depression.

  Kasper S, Praschak-Rieder N, Tauscher J, Wolf R. Kasper S, et al. Drug Saf. 1997 Oct;17(4):251-64. doi: 10.2165/00002018-199717040-00005. Drug Saf. 1997. PMID: 9352961 Review.
• The effects of mirtazapine on sleep in patients with major depressive disorder.

  Dolder CR, Nelson MH, Iler CA. Dolder CR, et al. Ann Clin Psychiatry. 2012 Aug;24(3):215-24. Ann Clin Psychiatry. 2012. PMID: 22860241 Review.